Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
Estimated
~$10 – $6,250
St. Jude Children's Research HospitalNCT06239272
Phase 1
A Phase Ib/II Study of the Mirdametinib in Combination With Palbociclib in Patients With Advanced Dedifferentiated Liposarcoma
The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, re…
Well Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT06843967